Trials / Recruiting
RecruitingNCT05939700
Mavacamten Pregnancy Surveillance Program
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Female
- Age
- 15 Years
- Healthy volunteers
- —
Summary
The purpose of this observational pregnancy safety study is to assess maternal, fetal, and infant outcomes after exposure to mavacamten at any time during pregnancy and/or breastfeeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mavacamten | Observational study of individuals exposed to at least 1 dose of mavacamten at any time during pregnancy and/or breastfeeding |
Timeline
- Start date
- 2023-11-09
- Primary completion
- 2027-04-30
- Completion
- 2027-04-30
- First posted
- 2023-07-11
- Last updated
- 2025-11-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05939700. Inclusion in this directory is not an endorsement.